Enveric Biosciences annual debt-to-equity ratio
2015
2016
2017
2018
2021
2022
2023
Enveric Biosciences Debt-to-Equity Ratio Growth & History (ENVB)
Enveric Biosciences's debt-to-equity ratio was 0.00 for fiscal 2023.
View full Enveric Biosciences company overviewEnveric Biosciences annual debt-to-equity ratio history
| Fiscal year | Period ended | Debt-to-equity ratio | Change | Growth |
|---|---|---|---|---|
| 2023 | 2023-12-31 | 0.00 | −0.00 | — |
| 2022 | 2022-12-31 | 0.00 | −0.00 | −44.97% |
| 2021 | 2021-12-31 | 0.01 | — | — |
| 2018 | 2018-12-31 | 0.12 | 0.06 | +99.86% |
| 2017 | 2017-12-31 | 0.06 | −0.37 | −86.52% |
| 2016 | 2016-12-31 | 0.43 | −18.91 | −97.77% |
| 2015 | 2015-12-31 | 19.34 | — | — |
Enveric Biosciences quarterly debt-to-equity ratio
Q2.15
Q4.15
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
| Fiscal quarter | Period ended | Debt-to-equity ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2023 | 2023-06-30 | 0.00 | −0.00 | −64.20% |
| Q1 2023 | 2023-03-31 | 0.00 | −0.00 | −42.50% |
| Q4 2022 | 2022-12-31 | 0.00 | −0.00 | −44.97% |
| Q3 2022 | 2022-09-30 | 0.00 | — | — |
| Q2 2022 | 2022-06-30 | 0.01 | — | — |
| Q1 2022 | 2022-03-31 | 0.01 | — | — |
| Q4 2021 | 2021-12-31 | 0.01 | — | — |
| Q3 2019 | 2019-09-30 | 0.10 | 0.10 | +38740.66% |
| Q2 2019 | 2019-06-30 | 0.12 | 0.05 | +69.86% |
| Q1 2019 | 2019-03-31 | 0.09 | 0.01 | +19.70% |
| Q4 2018 | 2018-12-31 | 0.12 | 0.06 | +99.86% |
| Q3 2018 | 2018-09-30 | 0.00 | −0.16 | −99.84% |
| Q2 2018 | 2018-06-30 | 0.07 | −0.05 | −42.98% |
| Q1 2018 | 2018-03-31 | 0.07 | −0.02 | −22.34% |
| Q4 2017 | 2017-12-31 | 0.06 | −0.37 | −86.52% |
| Q3 2017 | 2017-09-30 | 0.16 | −0.17 | −50.81% |
| Q2 2017 | 2017-06-30 | 0.13 | −2.15 | −94.40% |
| Q1 2017 | 2017-03-31 | 0.10 | — | — |
| Q4 2016 | 2016-12-31 | 0.43 | −18.91 | −97.77% |
| Q3 2016 | 2016-09-30 | 0.33 | — | — |
| Q2 2016 | 2016-06-30 | 2.28 | −2.19 | −49.00% |
| Q4 2015 | 2015-12-31 | 19.34 | — | — |
| Q2 2015 | 2015-06-30 | 4.47 | — | — |
Enveric Biosciences debt-to-equity ratio trends
Over the last five fiscal years, Enveric Biosciences's debt-to-equity ratio decreased from 0.12 to 0.00, a change of −0.12. The latest reported quarter, Q2 2023, shows 0.00.
About the metric
What the debt-to-equity ratio means
The debt-to-equity ratio compares interest-bearing debt with shareholders’ equity. It helps show how much debt financing a company uses relative to its accounting equity, but useful comparison levels vary by industry.
Calculation and source
How debt-to-equity is calculated
TickerStat calculates debt-to-equity as total interest-bearing debt divided by SEC-reported shareholders’ equity for the same balance-sheet date. Total liabilities are not treated as debt, and periods with non-positive equity are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Enveric Biosciences source filings ↗